Abstract
An interfacial cross-linking process was applied to hydrosoluble starch derivatives: hydroxyethylstarch (HES) and carboxymethylstarch (CMS). It resulted in stable microcapsules, which could be easily lyophilized and gave free-flowing powders. Sodium salicylate was encapsulated in HES microcapsules. In vitro dissolution studies indicated that these walls allow a prolonged release of the tracer. CMS microcapsules exhibited hydrophilic properties, as shown by water-induced swelling and gel formation. All cross-linked polysaccharide microcapsules were characterized by a total resistance to digestive media. However, when a protein, human serum albumin (HSA) or gelatin, was added to the starch derivatives in the aqueous phase, the process provided biodegradable microcapsules.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
